Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.
Alexandra Domnica HoeggerlVerena NunhoferWanda LauthNatalie BadstuberNina HeldGeorg ZimmermannChristoph GrabmerLisa WeidnerChristof JungbauerNadja LindlbauerHeidrun NeureiterTuulia OrtnerMaria FlammJürgen OsterbrinkEva RohdeSandra Laner-PlambergerPublished in: BMC infectious diseases (2023)
Our data suggest that PCS in per se healthy, immunocompetent adults cannot be ascribed to a reactivation of EBV.